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INVESTIGATION
Highly Efficient Site-Specific Mutagenesis in Malaria
Mosquitoes Using CRISPR
Ming Li,1 Omar S. Akbari,2 and Bradley J. White1
Department of Entomology, University of California, Riverside, California 92521
ABSTRACT Anopheles mosquitoes transmit at least 200 million annual malaria infections worldwide. De-
spite considerable genomic resources, mechanistic understanding of biological processes in Anopheles has
been hampered by a lack of tools for reverse genetics. Here, we report successful application of the
CRISPR/Cas9 system for highly efficient, site-specific mutagenesis in the diverse malaria vectors Anopheles
albimanus, A. coluzzii, and A. funestus. When guide RNAs (gRNAs) and Cas9 protein are injected at high
concentration, germline mutations are common and usually biallelic, allowing for the rapid creation of
stable mutant lines for reverse genetic analysis. Our protocol should enable researchers to dissect the
molecular and cellular basis of anopheline traits critical to successful disease transmission, potentially
exposing new targets for malaria control.
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Anophelesmosquitoes are the exclusive vectors of mammalian malaria
(White et al. 2011). Over the past decade, human malaria deaths have
declined by nearly 50%, primarily due to increased use of insecticides
that target the mosquito vector (Bhatt et al. 2015). However, emerging
physiological and behavioral resistance in Anopheles populations
threatens the sustainability of insecticidal control (David et al. 2005;
Edi et al. 2014; Sougoufara et al. 2014; Ranson and Lissenden 2016). In
order tomaintain and extend the hard-won progress of the past decade,
novel vector control strategies need to be developed and combined with
traditional chemical control. The development of new tools in the fight
against malaria mosquitoes is contingent upon improved mechanistic
knowledge of myriad mosquito biological processing, including blood
feeding, gametogenesis, gustation, immunity, olfaction, and metabo-
lism, among many others.
In 2002, the African malaria mosquito Anopheles gambiae was the
second arthropod to have its genome sequenced and, more recently, the
genomes of 16 other anophelines were sequenced (Holt et al. 2002;
Neafsey et al. 2013). Despite considerable genomic resources, progress
in dissecting the molecular and cellular biology of malaria mosquitoes
has been slow, primarily due to the difficulty in performing reverse genetic
techniques that are routine in model organisms. Currently, the vast ma-
jority of Anopheles genes have no known function (Giraldo-Calderón
et al. 2015), impeding the development of novel vector control strategies
reliant upon understanding how individual genes contribute to the bi-
ology of the mosquito. Previously, genome editing in Anopheles relied on
either transposon-based transgenesis with no control over where an in-
sertion occurred (Grossman et al. 2001; Nolan et al. 2002; Perera et al.
2002; Meredith et al. 2011; Carballar-Lejarazú et al. 2013; Pondeville et al.
2014) or highly inefficient and expensive, site-specific genome editing
technologies such as zinc finger nucleases or transcription activator-like
effector nucleases (Windbichler et al. 2007; Smidler et al. 2013). Recently,
the CRISPR/Cas9 genome editing technique has been successfully applied
to a diversity of organisms (Bassett et al. 2013; Hsu et al. 2014; Port et al.
2014; Basu et al. 2015; Dong et al. 2015; Gantz et al. 2015; Hall et al. 2015;
Kistler et al. 2015; Barrangou andDoudna 2016; Hammond et al. 2016; Li
et al. 2017; Sharma et al. 2017; Staahl et al. 2017; Li et al. 2017a; Li et al.
2017b). With this technology, researchers can directly edit or modulate
DNA sequences, allowing them to study the function of genes in vivo
(Hsu et al. 2014). When used for site-directed mutagenesis, Cas9 protein
and a small gRNA (sgRNA) that is complementary to a target sequence in
the genome are delivered to germ cells. The Cas9 and sgRNA complex
bind to the target sequence and cause a double-strand break, whichwill be
repaired through nonhomologous end joining (NHEJ) or microhomol-
ogy-mediated end joining (MMEJ) resulting in mismatches and indels
relative towild-type sequence (Bae et al. 2014; Basu et al. 2015;Maruyama
et al. 2015).When exons are targeted, suchmutagenesis will often result in
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premature stop codons or frameshifts that disrupt protein function. De-
spite high mutagenesis efficiency in other organisms, it is unclear if the
CRISPR/Cas9 systemwill prove to be efficient inAnopheles, as egg injection
alone often results in extremely high mortality and low transformation
efficiencies, perhaps due to the inherent fragility of the eggs themselves.
Here, we report successful development of an efficient site-specific muta-
genesis protocol using the CRISPR/Cas9 system in various anophelines,
facilitating reverse genetics in this important group of disease vectors.
MATERIALS AND METHODS
Mosquito strains
Four mosquito colonies were used in this study: A. coluzzii wild-type
strain NGS, A. gambiae white-eyed mutant strain M2 (MRA-105), A.
albimanus wild-type strain STECLA (MRA-126), and A. funestus wild-
type strain FUMOZ (MRA-127). Strains with accession numbers were
obtained from the Malaria Research and Reference Reagent Resource
Center (MR4). Mosquitoes were maintained in insectaries at the Uni-
versity of California, Riverside (UCR), under standard conditions
(White et al. 2011).
sgRNA design and generation
gRNAs were designed by searching both the sense and antisense strand
of exon 2 of the white gene (ACOM037804, AALB006905, and
AFUN003538) for the presence of protospacer-adjacent motifs with
the sequence NGG using ZIFIT (http://zifit.partners.org/ZiFiT/
ChoiceMenu.aspx) and CRISPR Design (http://crispr.mit.edu/)
(Xie et al. 2014). Linear, double-stranded DNA templates for sgRNAs
were generated by performing template-free PCR with Q5 high-fidelity
DNApolymerase (NEB), the forwardprimer of each gRNA, anduniversal-
sgRNAR. PCR conditions included an initial denaturation step of 98 for
30 sec, followed by 35 cycles of 98 for 10 sec, 58 for 10 sec, and 72 for
10 sec, followed by a final extension at 72 for 2 min. PCR products were
purified with magnetic beads using standard protocols. gRNAs were
generated by in vitro transcription (AM1334; Life Technologies) using
300 ng purified DNA as template in an overnight reaction incubated at
37. MegaClear columns (AM1908; Life Technologies) were used to
purify sgRNAs, whichwere then diluted to 1mg/ml, aliquoted, and stored
at 80 until use. Three possible off-target sites of each sgRNA in the
different mosquito species were identified based on the CHOPCHOPv2
software (Labun et al. 2016) and local sgRNACas9 package (Xie et al.
2014), and analyzed by using a T7 endonuclease I (T7EI) assay, respec-
tively. Briefly, genomic DNA was extracted from mosquitoes with the
DNeasy blood & tissue kit (QIAGEN) following the manufacturer’s pro-
tocol. Target loci were amplified by PCR and PCR product was purified
with a MinElute PCR purification Kit (QIAGEN). Next, 2 ml of NEB
buffer 2, 200 ng of purified PCR product, and ddH2O (to a total volume
of 19ml) were mixed together and a hybridization reaction conducted in
a PCR cycler with 5 min, 95; ramp down to 85 at22/sec; ramp down
to 25 at20.1/sec; and hold at 4. Next, 1 ml (10 U) of T7EI was added
and the reaction incubated at 37 for 15 min. The reaction was stopped
by adding 2 ml of 0.25 M EDTA and loaded immediately on a 1.5%
agarose gel. All primer sequences are listed in Supplemental Material,
Table S1 in File S1. Recombinant Cas9 protein from Streptococcus pyo-
genes was purchased from PNA Bio (CP01) and diluted to 1 mg/ml in
nuclease-free water with 20% glycerol, and stored in aliquots at 280.
Microinjection
Mixed sex pupae were allowed to eclose into a single (L24.5 ·W24.5 ·
H24.5 cm) cage. After allowing 5 d for mating, females were offered a
bovine bloodmeal using the Hemotek (model# PS5) blood feeding
system. A minimum of 60 hr was allowed for oogenesis, after which
ovicups filled with ddH20 and lined with filter paper were introduced
into cages, and females were allowed to oviposit in the dark. After
15 min, the ovicup was removed and unmelanized eggs were trans-
ferred onto a glass slide and rapidly aligned against a wet piece of filter
paper. Aluminosilicate needles (AF100-64-10; Sutter) pulled on a Sutter
P-1000 needle puller (heat 605, velocity 130, delay 80, pull 70, and
pressure 500) and beveled using a Sutter BV-10 beveler were used for
injections. An Eppendorf Femtojet was used to power injections, which
were performed under a compound microscope at 100·magnification.
Since eggs were injected prior to melanization, only 10–20 eggs were
injected at a time, after which fresh eggs were obtained. After injection,
eggs were floated in ddH20 and allowed to hatch spontaneously.
Mutation screens
The white-eye phenotype of G0 and G1 mosquitoes was assessed and
photographedunderaLeicaM165FCstereomicroscope.Tomolecularly
characterize CRISPR/Cas9-induced mutations, genomic DNA was
extracted from a single mosquito with a DNeasy blood & tissue kit
(QIAGEN) and target loci were amplified by PCR. For T7EI assays,
1 ml of T7EI (NEB) was added to 19 ml of PCR product, digested for
15 min at 37, and visualized on a 2% agarose electrophoresis gel
stained with ethidium bromide. To characterize mutations introduced
duringNHEJ orMMEJ, PCR products containing the sgRNA target site
were amplified, cloned into TOPO TA vectors (Life Technologies),
purified, and Sanger sequenced at the UCR Genomics core.
Data availability
Genomic DNA from mosquito strains produced here will be made
available upon request.
RESULTS
In order to rapidly and easily detect successful CRISPR/Cas9 mutagen-
esis, we wanted to target a gene where knockout of only a single allele
produces a visible phenotype. However, no dominant visible mutations
for Anopheles have been previously reported. Thus, we chose to target
the white gene, which codes a protein critical for eye pigment transport
(Besansky et al. 1995). Knockout of the white gene results in a change
fromwild-type red eye color to white (unpigmented) eye color, a simple
phenotype to score. Although the white allele is recessive, it is located
on the X chromosome and thus hemizygous in male anophelines
(XY sex determination system), meaning that successful knockout
of a single allele in males will result in the white-eye phenotype.
Mutagenesis efficiency is concentration- and sgRNA-
dependent
A. coluzzii belongs to theA. gambiae complex, which includes a number of
major African malaria vectors. To determine the efficacy of CRISPR/Cas9
mutagenesis in this species complex, we designed two sgRNAs targeting
exon 2of thewhite protein gene (ACOM037804). First,we usedAcsgRNA1
to test how different concentrations of both the sgRNA and Cas9 protein
affected mutagenesis rates. We found that both embryo survival and mu-
tagenesis rate were sgRNA and Cas9 concentration-dependent (Table 1).
Greater than 50% of embryos survived control injections with only water;
however, survival rates for embryos (37%) injected with even the lowest
concentration of sgRNA and Cas9 decreased relative to control. With in-
creasing concentrations of sgRNA and Cas9, embryo survival further de-
creased. Indeed, only 11% of embryos survived injections with the highest
concentrations tested. Conversely, concentrations of sgRNA andCas9were
positively correlated withmutagenesis rates; 46% ofmales injected with the
lowest concentration had mosaic white eyes, while a remarkable 100% of
654 | M. Li, O. S. Akbari, and B. J. White
males injected with the highest concentration had mosaic eyes (Figure 1
and Table 1). Importantly, at higher injection concentrations, a majority of
injected females also had mosaic eyes. Since the white gene is recessive, the
production of mosaic females demonstrates that the CRISPR/Cas9 system
can mutate both copies of diploid Anopheles genes. Notably, we also ob-
served G0-injected males and females with completely white eyes, suggest-
ing that the vast majority of cells in the eyes were mutated. Based on the
above results, we used an sgRNA concentration of 120 ng/ml and a Cas9
protein concentration of 300 ng/ml, which balances survival and mutagen-
esis efficiency, to further explore the CRISPR/Cas9 system inAnopheles. To
determine if the sgRNA sequence had an effect on mutagenesis rate, we
compared AcsgRNA1 from above against a second sgRNA (AcsgRNA2)
targeting white. We found that AcsgRNA1 (93, 87%) produced mosaic G0
males and females at a much higher frequency than AcsgRNA2 (32, 25%),
suggesting that the sgRNA sequence can have a large impact on mutagen-
esis efficiency (Table 2).
Confirmation of germline mutations and site specificity
While mosaic G0 mosquitoes can be used for reverse genetics, the
creation of stable, mutant lines permits more thorough investigation of
gene function. Thus, we wanted to determine the proportion of G0
mosaic-eyed A. coluzzi that possessed germline mutations. To obtain
the germline mutation rate, we crossed G0 mosaic-eyed males with
females of an existing white-eye mutant line of A. coluzzii (M2) that
was established . 20 yr ago (Figure S2A in File S1) (Mason 1967;
Besansky et al. 1995; Benedict et al. 1996). Hemizygous male progeny
of this cross will all have white eyes since they inherit a maternal
mutated white gene; however, homozygous females will only have
white eyes if they inherit a mutant allele from both parents. A remark-
able 93% of G0 mosaic males injected with AcsgRNA1 produced G1
females with white eyes, while 88% of G0 AcsgRNA2 mosaic males
passed on white-eye mutations to G1 female progeny (Table 2). To
determine if female mosquitoes withmosaic eyes could also pass on the
mutation, we performed a bulk cross of mosaic G0 males with mosaic
G0 females and found that 83% (male 86% and female 81%) of the G1
progeny from AcsgRNA1-injected mosquitoes had fully white eyes, while
47% (male 45% and female 49%) of G1 progeny fromAcsgRNA2-injected
mosquitoes had fully white eyes (Table 2). We have now maintained
multiple, white-eyed mutant lines in the laboratory for .15 generations,
proving that the mutations introduced by CRISPR/Cas9 are highly stable.
n Table 1 Effect of sgRNA and Cas9 concentration on A. coluzzii survival and mutagenesis
AcsgRNA 1 Cas9 Number Injected Survivors Mosaic (%)
M F Total (%) M (%) F (%)
No injection No injection 300 137 118 255 (85) 0 0
Water Water 217 69 52 121 (56) 0 0
30 (ng/ml) 100 (ng/ml) 185 31 38 69 (37) 32 (46) 0
60 200 251 48 33 81 (32) 48 (59) 0
120 300 219 31 16 47 (21) 29 (94) 12 (75)
240 400 177 22 11 33 (19) 20 (91) 9 (82)
480 500 228 12 12 24 (11) 12 (100) 10 (83)
M, male; F, female.
Figure 1 CRISPR/Cas9 efficiently
generates heritable, site-specific
mutations in diverse Anopheles
mosquitoes. On the left, represen-
tative images of wild-type anoph-
eline eyes are shown for each
species. In the center are repre-
sentative G0 mosaic white-eyed
mutant mosquitoes that were in-
jected with sgRNA and Cas9 as
embryos. On the right are repre-
sentative homozygous white-eyed
mutant G1 mosquitoes generated
by crossing mosaic G0 male and
female mosquitoes. CRISPR, clus-
tered regularly interspaced short
palindromic repeats; sgRNA, small
guide RNA.
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The combination of good G0 survival, biallelic mutation, and high
germline transmission allows for the rapid creation of knockout
A. coluzzii lines using CRISPR/Cas9.
To confirm that the mosaic eye phenotype was caused by loss-
of-function of the white gene, we performed a T7EI assay on five
randomly chosen G0 AcsgRNA1 and AcsgRNA2 male mosqui-
toes with mosaic eyes. In the T7EI assay, T7EI will cut when NHEJ
or MMEJ of the CRISPR-induced double strand break introduces
a SNP or indel relative to the wild-type allele, whereas no diges-
tion will occur in mosquitoes with two wild-type alleles. As
expected, PCR fragments of the white gene from mosaic-eyed
males were consistently cut into small bands by T7EI, while no
activity was observed in nonmosaic male mosquitoes (Figure S4,
A–E in File S1), confirming that the white-eye phenotype is
caused by disruption of the white coding sequence. To sample
the spectrum of mutations introduced by NHEJ or MMEJ, we
performed Sanger sequencing of PCR products containing the
two sgRNA target sites in G1 mosquitoes with white eyes. The
sequencing results confirmed the presence of indels that were
induced by NHEJ or MMEJ (Figure S3, A and B and Table S2
in File S1) in all mutant mosquitoes, which ranged in size from
2 to 54 bp. Finally, we screened for off-target activity of both
sgRNAs by T7EI assay. Across three potential off-target loci for
both sgRNAs, no evidence of mutagenesis was detected in G0
mosaic males, indicating high specificity of the sgRNAs (Figure
S5 in File S1).
CRISPR/CAS9 activity in diverse Anopheles
To determine the applicability of the CRISPR/Cas9 system to
diverse Anopheles species, we performed injections targeting
white in A. albimanus (a minor vector of malaria on South America)
and A. funestus (a major, understudied malaria vector in Africa)
(Neafsey et al. 2013). For each species, we designed two sgRNAs
targeting white and injected the individual sgRNAs (120 ng/ml)
and Cas9 (300 ng/ml) directly into eggs.
As found in other studies, A. albimanus survived injections at a
rate comparable toA. coluzzii (Perera et al. 2002). For AasgRNA1, wen
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Figure 2 Morphology of eggs differs dramatically among anophelines.
Eggs of the three species of Anopheles used in this study alongside an
egg of the yellow fever mosquito Ae. aegypti for size comparison. Note
the difference in pole shape between A. albimanus and A. funestus
eggs, which likely contributes to differences in both survival and muta-
genesis rates between these two species.
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found that 91% of G0 males had mosaic white eyes, while 74% of G0
females were mosaics. Interestingly, injection of AasgRNA2 pro-
duced no mosquitoes with mosaic eyes, further reinforcing the im-
pact of sgRNA choice on mutagenesis efficiency. Since no previously
generated white-eyed line of A. albimanus was available, we bulk
crossed AasgRNA1 G0 mosaic males and females to determine
germline mutation rates (Table 2). Over 61% of the G1 progeny
from the cross possessed fully white eyes, suggesting high germline
mutagenesis efficiency in A. albimanus. As with A. coluzzii, T7EI
assays consistently detected mutations in white in G0 mosaic males
(Figure S4 in File S1) and sequencing showed indels in mosaic males
ranging from 2 to 11 bp (Figure S3 in File S1). Additionally, no
mutations were detected using T7EI assays at three potential off-
target sites for AasgRNA1 (Figure S5 in File S1).
The survival rate of A. funestus embryos injected with either of two
sgRNAs targeting the white gene (AfsgRNA1 and AfsgRNA2) was less
than half that of A. coluzzii and A. albimanus. (Table 2). We attribute
the lower survival rate to the unique morphology of A. funestus eggs at
the poles (Figure 2), which makes injection challenging. Despite lower
survival, a high proportion of G0 males (53 and 24%) and females
(64 and 25%) for both sgRNAs displayed mosaic white eyes. Bulk
crossing of G0 male and female mosaics (Figure S2B in File S1) pro-
duced 67% (AfsgRNA1) or 57% (AfsgRNA2) G1 progeny with fully
white eyes, demonstrating high germline mutagenesis rates. As with
previous species, the T7EI assay consistently identified mosaic males
(Figure S4 in File S1) and Sanger sequencing revealed diverse indels (2–
34 bp) in mutated males (Figure S3 in File S1). No mutagenic activity
was detected for either sgRNA at the three most likely off-target geno-
mic sites (Figure S5 in File S1).
DISCUSSION
The CRISPR/Cas9 system offers the possibility of precise, efficient, and
cost-effective mutagenesis in nonmodel organisms (Barrangou and
Doudna 2016). While considerable genomic resources have been de-
veloped for malaria mosquitoes, no efficient tools for performing re-
verse genetics in these species exist, slowing the development of
genetics-based vector control. Studies of the CRISPR/Cas9 system in
the distantly related (diverged 145–200 million years ago) mosquito
Aedes aegypti have demonstrated G0 mutagenesis rates between 3 and
50%, with high variability among injection operators and different
sgRNAs (Basu et al. 2015; Kistler et al. 2015). While no systematic
studies of CRISPR/Cas9 mutagenesis rates on any anopheline mosqui-
toes have been conducted, a few groups developing gene drive-related
technologies (Adelman et al. 2017; Akbari et al. 2015; Champer et al.
2016; Marshall et al. 2015; Marshall et al. 2017) have recently reported
high rates of mutagenesis when gRNAs and Cas9 were directly inte-
grated into the genome of two Anopheles species (Gantz et al. 2015;
Galizi et al. 2016; Hammond et al. 2016).
In summary, we report remarkably high rates of survival and
mutagenesis in three different Anopheles species co-injected with
Cas9 protein and sgRNAs targeting the white gene. Importantly, we
describe the first, successful genetic engineering of A. funestus, demon-
strating that the CRISPR/Cas9 system may even be useful in species
where previous genome editing techniques proved too inefficient for
practical use. Additionally, since high concentrations of sgRNA and
Cas9 result in biallelic mutations, stable mutant lines can be rapidly
generated, even when no visible marker is present. The following pro-
cedure can be used to generate such lines: (1) inject sgRNA and Cas9
into mixed sex eggs, (2) cross G0 survivors en masse, (3) isolate G0
females into individual ovicups, (4) screen five G1 larvae from each
family for mutations (sequencing, T7EI, or an alternative assay), (5)
conduct full sibling mating of families in which all G1 larvae are mu-
tants, and (6) confirm stable generation of a mutant line by sequencing
of G2 mosquitoes. The ability to rapidly and consistently create stable
knockout lines should greatly accelerate mechanistic research into key
cellular and molecular pathways in malaria mosquitoes.
Wenote that cleavage efficiencyof the sgRNA/Cas9complex is target
site-dependent. In mammalian systems, it has been reported that the
chromatin environment around the target site andcertain features of the
sgRNA sequence are major factors affecting the efficiency of DSB
generation (Doench et al. 2014; Kuscu et al. 2014; Wang et al. 2015).
Due to the limited number of sgRNAs we tested, we are unable to
confirm whether these observations can be extended into Anopheles.
However, the complete failure of AasgRNA2 to cause knockout is likely
due to low thermodynamic stability of the sgRNA/Cas9 complex, or
secondary structure at the target site preventing binding (Bassett and
Liu 2014; Moreno-Mateos et al. 2015).
Having demonstrated the utility of theCRISPR/Cas9 system for site-
specificmutagenesis ofAnopheles, a logical next step is to systematically
determine the efficiency of the system for integrating variously sized
constructs into anopheline genomes via HDR. The ability to conduct
efficient deletion and addition of known sequences at specific genomic
positions will greatly speed progress toward genetic methods, such as
gene drive, for the control of malaria vectors.
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